Mulyukov Z - Search Results

1

Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data.

Agostini H, Mulyukov Z, Tsilimbaris M, Calvo P, Bucher F, Gaucher D, Pigeolet E, Colafrancesco V, Clemens A. Agostini H, et al. Among authors: mulyukov z. Curr Eye Res. 2020 Oct;45(10):1298-1301. doi: 10.1080/02713683.2020.1731832. Epub 2020 Feb 26. Curr Eye Res. 2020. PMID: 32065533 Clinical Trial.

2

Neovascular Age-Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect.

Mulyukov Z, Weber S, Pigeolet E, Clemens A, Lehr T, Racine A. Mulyukov Z, et al. CPT Pharmacometrics Syst Pharmacol. 2018 Oct;7(10):660-669. doi: 10.1002/psp4.12322. Epub 2018 Aug 15. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 30043524 Free PMC article.

3

Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach.

Xiong Y, Pigeolet E, Mulyukov Z, Margaron P, Racine A, Clemens A. Xiong Y, et al. Among authors: mulyukov z. Contemp Clin Trials. 2019 May;80:34-39. doi: 10.1016/j.cct.2019.03.008. Epub 2019 Mar 21. Contemp Clin Trials. 2019. PMID: 30904595 Free article. Clinical Trial.

4

EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies.

Dugel PU, Jhaveri CD, Chakravarthy U, Wykoff CC, Singh RP, Hamilton R, Weissgerber G, Mulyukov Z, Holz FG. Dugel PU, et al. Among authors: mulyukov z. Retina. 2022 Mar 1;42(3):511-518. doi: 10.1097/IAE.0000000000003349. Retina. 2022. PMID: 34923515 Clinical Trial.

5

Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials.

Singer M, Khanani AM, Wolf A, Flores R, Chhablani J, B G, Clemens A, Gedif K, Liu X, Mulyukov Z, Querques G. Singer M, et al. Among authors: mulyukov z. Ophthalmologica. 2022;245(4):315-322. doi: 10.1159/000524245. Epub 2022 Mar 28. Ophthalmologica. 2022. PMID: 35344964 Free article. Clinical Trial.

6

Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis.

Schmidt-Erfurth U, Mulyukov Z, Gerendas BS, Reiter GS, Lorand D, Weissgerber G, Bogunović H. Schmidt-Erfurth U, et al. Among authors: mulyukov z. Eye (Lond). 2023 Apr;37(6):1160-1169. doi: 10.1038/s41433-022-02077-4. Epub 2022 May 6. Eye (Lond). 2023. PMID: 35523860 Free PMC article. Clinical Trial.

7

Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.

Terheyden JH, Pondorfer SG, Behning C, Berger M, Carlton J, Rowen D, Bouchet C, Poor S, Luhmann UFO, Leal S, Holz FG, Butt T, Brazier JE, Finger RP; MACUSTAR consortium. Terheyden JH, et al. Br J Ophthalmol. 2023 Aug;107(8):1144-1150. doi: 10.1136/bjophthalmol-2021-320848. Epub 2022 Mar 30. Br J Ophthalmol. 2023. PMID: 35354561 Free PMC article. Clinical Trial.

8

Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report.

Saßmannshausen M, Behning C, Isselmann B, Schmid M, Finger RP, Holz FG, Schmitz-Valckenberg S, Pfau M; MACUSTAR Consortium; Thiele S. Saßmannshausen M, et al. Sci Rep. 2022 Sep 2;12(1):14933. doi: 10.1038/s41598-022-18875-5. Sci Rep. 2022. PMID: 36056113 Free PMC article.

9

Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report.

Garzone D, Terheyden JH, Morelle O, Wintergerst MWM, Saßmannshausen M, Schmitz-Valckenberg S, Pfau M, Thiele S, Poor S, Leal S, Holz FG, Finger RP; MACUSTAR Consortium. Garzone D, et al. Sci Rep. 2022 Dec 19;12(1):21911. doi: 10.1038/s41598-022-26223-w. Sci Rep. 2022. PMID: 36535990 Free PMC article.

10

Characteristics and Spatial Distribution of Structural Features in Age-Related Macular Degeneration: A MACUSTAR Study Report.

Saßmannshausen M, Behning C, Weinz J, Goerdt L, Terheyden JH, Chang P, Schmid M, Poor SH, Zakaria N, Finger RP, Holz FG, Pfau M, Schmitz-Valckenberg S, Thiele S; MACUSTAR Consortium Members. Saßmannshausen M, et al. Ophthalmol Retina. 2023 May;7(5):420-430. doi: 10.1016/j.oret.2022.12.007. Epub 2022 Dec 20. Ophthalmol Retina. 2023. PMID: 36563964 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters